{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:45:54Z","timestamp":1760057154711,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ajem.2007.11.014","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T14:53:27Z","timestamp":1220799207000},"page":"808-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The approach to optimizing stroke care"],"prefix":"10.1016","volume":"26","author":[{"given":"Peter D.","family":"Panagos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2007.11.014_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.STR.0000217971.88034.e9","article-title":"Increasing rates of dementia at time of declining mortality from stroke","volume":"37","author":"Ukraintseva","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib2","first-page":"e85","article-title":"Heafs rt disease and stroke statistics\u20142006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2007.11.014_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-1-2","article-title":"Incidence and characteristics of total stroke in the United States","volume":"1","author":"Williams","year":"2001","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ajem.2007.11.014_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.STR.0000116183.50167.D9","article-title":"Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study","volume":"35","author":"Hardie","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib5","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/01.STR.27.9.1459","article-title":"Lifetime cost of stroke in the United States","volume":"27","author":"Taylor","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.STR.0000165926.74213.e3","article-title":"Recurrent stroke risk is higher than cardiac event risk after initial stroke\/transient ischemic attack","volume":"36","author":"Brown","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/01.wnl.0000176058.09848.bb","article-title":"Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly","volume":"65","author":"Kaplan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/01.wnl.0000175983.76110.59","article-title":"Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease","volume":"65","author":"Kern","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.STR.13.3.290","article-title":"Survival and recurrence following stroke. The Framingham Study.","volume":"13","author":"Sacco","year":"1982","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/hs0402.105246","article-title":"Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease","volume":"33","author":"Vickrey","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.50.1.208","article-title":"Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989","volume":"50","author":"Petty","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib12","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","article-title":"Short-term prognosis after emergency department diagnosis of TIA","volume":"284","author":"Johnston","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2007.11.014_bib13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","article-title":"Incidence and short-term prognosis of transient ischemic attack in a population-based study","volume":"36","author":"Kleindorfer","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11910-001-0075-x","article-title":"Choices in medical management for prevention of acute ischemic stroke","author":"Fleck","year":"2001","journal-title":"Curr Neurol Neurosci Rep."},{"key":"10.1016\/j.ajem.2007.11.014_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/01.WNL.0000042780.64786.EF","article-title":"A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA","volume":"60","author":"Johnston","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.STR.30.9.1991","article-title":"Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association","volume":"30","author":"Wolf","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(06)70408-2","article-title":"Recent advances in management of transient ischaemic attacks and minor ischaemic strokes","volume":"5","author":"Rothwell","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajem.2007.11.014_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/01.WNL.0000152985.32732.EE","article-title":"Timing of TIAs preceding stroke: time window for prevention is very short","volume":"64","author":"Rothwell","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib19","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1001\/jama.283.23.3102","article-title":"Recommendations for the establishment of primary stroke centers. Brain Attack Coalition","volume":"283","author":"Alberts","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2007.11.014_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2005-923528","article-title":"Acute stroke treatment in the community: improving our performance and expanding our options","volume":"25","author":"Russman","year":"2005","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ajem.2007.11.014_bib21","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0749-3797(03)00206-X","article-title":"Low public recognition of major stroke symptoms","volume":"25","author":"Greenlund","year":"2003","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajem.2007.11.014_bib23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.STR.0000162716.82295.ac","article-title":"Development and validation of the stroke action test","volume":"36","author":"Billings-Gagliardi","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ajem.2007.11.014_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/01.STR.0000044170.46643.5E","article-title":"Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the Face Arm Speech Test","volume":"34","author":"Harbison","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/10903120190939463","article-title":"A comparison of emergency medical services times for stroke and myocardial infarction","volume":"5","author":"Evenson","year":"2001","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.ajem.2007.11.014_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.56.8.1015","article-title":"Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility","volume":"56","author":"Barber","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2007.11.014_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/WNL.59.1.13","article-title":"Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)","volume":"59","author":"Coull","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","article-title":"Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial","volume":"31","author":"Chen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib31","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Albers","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2007.11.014_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ajem.2007.11.014_bib33","first-page":"S1","article-title":"ADA clinical practice recommendations","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajem.2007.11.014_bib34","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/01.STR.0000072985.24967.7F","article-title":"Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register","volume":"34","author":"Hillen","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib35","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham Study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2007.11.014_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.STR.25.5.951","article-title":"Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program.","volume":"25","author":"Burchfiel","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib37","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation and Treament of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 4","key":"10.1016\/j.ajem.2007.11.014_bib38","first-page":"326S","article-title":"Obesity and disease management: effects of weight loss on comorbid conditions","volume":"9","author":"Anderson","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.ajem.2007.11.014_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1212\/WNL.39.3.339","article-title":"Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke: results of a case-control study at three urban medical centers in Chicago, Illinois","volume":"39","author":"Gorelick","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2007.11.014_bib40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.CIR.96.4.1089","article-title":"Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke","volume":"96","author":"Lightwood","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2007.11.014_bib41","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.STR.0000165902.18021.5b","article-title":"Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry","volume":"36","author":"Reeves","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.03.001","article-title":"Characterization of ischemic events and use of prescription antiplatelet and anticoagulant agents after stroke or transient ischemic attack","volume":"14","author":"Zaher","year":"2005","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ajem.2007.11.014_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/01.STR.31.2.469","article-title":"Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population","volume":"31","author":"Hillen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib44","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.STR.0000017877.62543.14","article-title":"How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack?","volume":"33","author":"Mouradian","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib45","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2007.11.014_bib46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2007.11.014_bib47","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2007.11.014_bib48","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2007.11.014_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/eurheartj\/ehi684","article-title":"Aspirin and clopidogrel resistance: an emerging clinical entity","volume":"27","author":"Wang","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2007.11.014_bib50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajem.2007.11.014_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.STR.0000106763.46123.F6","article-title":"Antiplatelet effect of aspirin in patients with cerebrovascular disease","volume":"35","author":"Alberts","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2007.11.014_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.2005.00419.x","article-title":"Aspirin resistance in secondary stroke prevention","volume":"113","author":"Berrouschot","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ajem.2007.11.014_bib53","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2007.11.014_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0049-3848(91)90085-B","article-title":"Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients","volume":"63","author":"Grotemeyer","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajem.2007.11.014_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.ajem.2007.11.014_bib56","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2007.11.014_bib57","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajem.2007.11.014_bib58","doi-asserted-by":"crossref","unstructured":"Sztriha LK, Sas K, Vecsei L: Aspirin resistance in stroke: 2004. J Neurol Sci 2005;229-230:163-169.","DOI":"10.1016\/j.jns.2004.11.023"},{"key":"10.1016\/j.ajem.2007.11.014_bib59","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot study including 180 post-stroke patients","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajem.2007.11.014_bib60","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2007.11.014_bib61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2007.11.014_bib62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2007.11.014_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.63.1.20","article-title":"Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist","volume":"63","author":"Fisher","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajem.2007.11.014_bib64","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2007.11.014_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ahj.2004.03.028","article-title":"Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial","volume":"148","author":"Bhatt","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ajem.2007.11.014_bib66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.0000112378.09325.F9","article-title":"Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance","volume":"109","author":"Lau","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2007.11.014_bib67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1160\/TH04-02-0105","article-title":"Pharmacokinetics of clopidogrel after administration of a high loading dose","volume":"92","author":"Taubert","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajem.2007.11.014_bib68","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2007.11.014_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ajem.2007.11.014_bib70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archneur.62.3.403","article-title":"Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations","volume":"62","author":"Sacco","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajem.2007.11.014_bib71","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2007.11.014_bib72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000100105","volume":"23","author":"Diener","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ajem.2007.11.014_bib73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000090207","article-title":"Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness","volume":"21","author":"Serebruany","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ajem.2007.11.014_bib74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","article-title":"Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services","volume":"328","author":"Coull","year":"2004","journal-title":"BMJ"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675707007395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675707007395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:10:00Z","timestamp":1760022600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675707007395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0735675707007395"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2007.11.014","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The approach to optimizing stroke care","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2007.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}